the vaccine – Page 7 – Communicable Diseases Research

Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection

Article

Published on 2022-09-162022-11-15
Journal: Vaccine [Category] SARS, 변종, 진단,

Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination

Article

Published on 2022-09-162022-11-15
Journal: Vaccine [Category] SARS, 진단,

A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?

Article

Published on 2022-09-162022-11-15
Journal: Medicine [Category] SARS, 변종, 진단,

Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults

Article

Published on 2022-09-142022-11-15
Journal: Journal of Virology [Category] SARS, 변종, 진단,

[키워드] Adolescent adolescents adolescents and adult adolescents and adults Adults age antibody Antibody binding antibody binding titers approved Beta binding binding antibody BNT162b2 BNT162b2 vaccine booster booster dose booster vaccination breadth changes in children circulating clinical trial Cohort Coverage COVID-19 Delta demonstrated dose drug Effectiveness Efficacy evaluate FDA food Gamma highlight Hospitalization humoral immune response lack less Loss magnitude mounted mRNA vaccine neutralization Neutralizing antibody response omicron Omicron (B.1.1.529) pandemic pediatric Pfizer Pfizer-BioNTech Pfizer-BioNTech (BNT162b2) plasma populations PROTECT reduction reported Research response responses against robust SARS-CoV-2 seasonal beta coronavirus the antibody response the SARS-CoV-2 the vaccine vaccination Vaccine vaccine-induced antibody response Vaccine-induced immunity variant variant of concerns (VOCs) variants viral variant Virus neutralization virus spike protein VoC VOCs while wild-type SARS-CoV-2
[DOI] 10.1128/jvi.00582-22 PMC 바로가기

SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study

Article

Published on 2022-09-142022-11-15
Journal: Scientific Reports [Category] SARS, 진단, 치료기술,

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

Article

Published on 2022-09-102022-11-15
Journal: Journal of clinical oncology : official journal of [Category] SARS, 변종, 진단, 치료기술,

[키워드] affected analyzed antibody B-cell malignancy BNT162b2 Booster vaccine Characteristics Critical Delta detect detectable determinant disease environmental exposure Factors greater hosts Immunocompromised implication increased risk induction initial lack Live virus Moderna MONITOR Mortality mRNA1273 much lower Multiple myeloma Myeloma NAb neutralization neutralize neutralizing antibody neutralizing capacity nucleocapsid Patient patients Pseudovirus neutralization assay quantified RBD receiving response SARS CoV-2 Seroconversion Serologic response significantly spike receptor-binding domain the vaccine Treatment vaccination Vaccine vaccine-induced antibody variant viral neutralization virus virus-neutralizing were measured
[DOI] 10.1200/JCO.21.02257 PMC 바로가기

mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells

Article

Published on 2022-09-072022-11-16
Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), SARS, 유전자 메커니즘,

SARS CoV- 2 vaccination induces antibodies against cardiolipin

Article

Published on 2022-09-072022-11-15
Journal: BMC Research Notes [Category] SARS, 진단,

Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine

Article

Published on 2022-09-062022-11-16
Journal: Nature Communications [Category] SARS, 변종, 치료기술,

Relative Effectiveness of COVID-19 Vaccination in Healthcare Workers: 3-Dose Versus 2-Dose Vaccination

Article

Published on 2022-09-052022-11-16
Journal: Journal of Korean medical science [Category] SARS, 변종,